Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Ondansetron + Dexamethasone for Acute Nausea
NCT02985840Phase 4Terminated
- Sponsor
- OhioHealth
- Start
- Jan 2014
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in nausea ((none)) and abdominal pain, sponsored by OhioHealth. Primary endpoint: Number of Participants With Need for Additional Nausea Medications at 1 hour. Started Jan 2014; status: terminated.
02
Drugs
dexamethasone
03
Conditions
nausea ((none))abdominal pain
Beyond the preview
Go deeper on NCT02985840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02985840.